Sonnet BioTherapeutics Holdings, Inc. operates as a clinical stage biotechnology company. The Company develops fully human albumin binding technology that helps the development of innovative targeted biologic drugs with enhanced single-or bi-specific mechanisms. Sonnet BioTherapeutics Holdings serves customers in the United States.

424B3 | Prospectus

S-3 | Registration statement for specified transactions by certain issuers

Current Report (Form 8-K | Period ending 2024-06-19)

Current Report (Form 8-K | Period ending 2024-06-13)

Current Report (Form 8-K | Period ending 2024-05-22)

United States

Bellicum Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company focuses on discovering and developing novel cellular immunotherapies for cancer, tumors, and blood diseases. Bellicum Pharmaceuticals serves patients in the United States.

Navidea Biopharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision radiopharmaceutical diagnostics for diseases such as cancer.

Aravive, Inc. operates as a biotechnology company. The Company develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. Aravive serves patients in the United States.

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It offer tests for disorders in cardiovascular, hereditary cancer, neurology, pediatrics, and other rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.

Salarius Pharmaceuticals Inc is a clinical-stage oncology company. The Company specializes in targeting the epigenetic causes of cancers and developing treatments for patients. Salarius Pharmaceuticals serves patients and customers in the State of Texas.

Trevena, Inc. develops pharmaceutical products. The Company offers discovery and development of agents targeting G-protein coupled receptors and therapies and drugs that treat acute heart failure, acute chronic pain, and depression. Trevena serves customers throughout the United States.

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic, and infectious diseases.

Otonomy, Inc. operates as a clinical stage biopharmaceutical company. The Company develops therapeutics for treatment of inner and middle ear disorders.

Infinity Pharmaceuticals, Inc. researches and develops cancer drugs.  The Company uses small molecule drug technologies in the development of its products.

Organovo Holdings, Inc. operates as a biology company. The Company focuses on bio-printing technology and creating tissues for research and medical applications.

Bionomics Limited operates as a biotechnology company, which specializes in the genetics field.  The Company, which is affiliated with a number of research institutions, seeks to develop a variety of genomic, genetic, molecular and cell biology techniques, which they believe will help demonstrate the onset and progression of diseases like epilepsy and breast cancer.

Bioxyne  Limited operates as a biotechnology company.  The Company specializes in the research, development and commercialization of diseases related to chronic obstructive pulmonary disease(COPD).

DorsaVi Ltd. develops and sells wireless sensor movement monitoring systems. The Company's technology is used by the to monitor workplace and sports related injury and pain.

Regeneus Ltd is a regenerative medicine company focused on using the regenerative capacities of adipose-derived cells to develop innovative cell therapies for humans and animals.

Hybrigenics S.A. is a biotechnology and pharmaceutical company. The Company develops therapeutics against cancer as well as develops platforms to identify, validate and inhibit protein interactions.

Neovacs is a biotechnology company.  The Company researches immunotherapy applications for autoimmune diseases, inflammatory diseases such as rheumatoid arthritis, cancer and other conditions.

PAION AG, together with its subsidiaries, operates as a biopharmaceutical company focusing on the clinical development of drug candidates for diseases or interventions with a substantial unmet medical need.

Quantum Genomics SAS is a global biotechnology company. The Company researches and develops treaments for human diseases, including cardiovascular diseases, neurology and metabolic related diseases.

Oxurion NV is a biopharmaceutical company focused on developing treatments for diabetic eye disease. The Company's R&D pipeline of disease modifying drug candidates focuses on diabetic retinopathy (DR) and diabetic macular edema (DME). Oxurion has disease-modifying molecules in its pipeline addressing all segments of the DR and DME market.

Targovax AS develops biopharmaceutics. The Company specializes in creation of therapeutic vaccines for various types of cancer. Targovax serves the healthcare sector.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00